Blocking CCL5/RANTES–CCR5 by genetic deletion or ICV injection of an antagonist inhibited hypothalamic insulin signaling and insulin resistance, indicating that this chemokine has a role in suppressing S6K-mediated negative feedback input to insulin signaling. This evidence concerns the gene CCL5 and Insulin resistance.